Source legit

Growth hormone releasing peptides protocol log

Who We Are

Mechanism, dose window, half-life, stack pairing, sourcing pathway. The sermorelin entry, plus adjacent GHRPs and GHRH analogs adults actually run.

Start your consultation

operates sermorelin-peptides.com as an editorial reference about growth hormone releasing peptides, the science around their use, and the regulatory architecture that frames how they are dispensed in the United States. The site is published by an independent editorial team that writes long-form pieces about a narrow technical field.

Our mission

The mission of is to be the place a curious reader lands when they search for substantive coverage of sermorelin and its analogs. Material online about peptides tends to fall into two buckets. On one side, marketing pages strip out caveat and overstate certainty. On the other, dense journal abstracts assume a reader who already speaks the language. The space we work in sits between those two: rigorous enough to track the literature, plain enough to read as a thinking adult.

We write so that a reader leaves an article with a better mental model than they brought to it.

How we source

Every article is built on primary material. Where the topic is pharmacology we read the underlying study, not a press release about it. Where the topic is regulation we read the regulator’s plain text — Federal Food, Drug, and Cosmetic Act sections, FDA guidance documents, USP monographs, state pharmacy board opinions — instead of a secondhand paraphrase. Where the topic is a compounded preparation we cross-check against published monographs and against the documented procedures that an FDA-registered outsourcing facility would follow.

When the literature is thin or contested, we say so in plain language inside the article. A reader who learns where the evidence stops is better off than a reader who is handed a polished sentence that quietly elides the gap.

Review process

Drafts go through internal review before publication. A second editor reads for factual accuracy against the cited source, a third reads for tone and for the careful framing that any medical topic deserves. We update articles when the underlying material moves: a new paper that revises a half-life estimate, a regulator’s guidance that reshapes a compounding pathway, a monograph that supersedes earlier text. Significant revisions are reflected in the body of the article.

The team

The editorial team is small, deliberately. A short bench keeps the voice of the site consistent and keeps the technical quality high. Editors come from backgrounds in clinical research, regulatory affairs, and medical journalism. Contributors are domain specialists who write because they care about the field, not because they are filling a content quota.

Reaching us

The fastest channel for editorial questions, correction requests, and press inquiries is the contact page. For formal correspondence write to at , or call .

Sermorelin, profile entry in the United States, USA

A 29 amino acid GHRH analog that binds the same pituitary receptor as endogenous growth hormone releasing hormone. Triggers a physiologic pulse of growth hormone in the body's own pattern, while the natural negative feedback loop stays intact. Approved branded form discontinued. For adults across the United States, USA, modern administration is compounded, prescription only, from US 503A and 503B pharmacies.

Dark laboratory shelf with sermorelin peptide vials lit by a thin lime accent

Mechanism

Binds pituitary GHRH receptor, triggers pulsatile GH release. Feedback loop preserved.

Dose window

100 to 500 mcg subcutaneous nightly. Most US telehealth protocols sit at 200 to 300 mcg.

Cycle length

12 weeks standard. Re-evaluate IGF-1 at week 12. Off-cycle 4 to 8 weeks if continuing.

Lab markers

IGF-1, fasting glucose, HbA1c, lipids, basic metabolic panel.

Common stack

Sermorelin GHRH plus ipamorelin GHRP for synergistic pulse amplification.

Side effect floor

Injection site redness, transient flush, occasional headache. Hypoglycemia screened.

Adjacent peptides commonly stacked

Sermorelin rarely runs alone in serious protocols. The two adjacent classes worth understanding are GHRPs, which amplify GH pulse amplitude, and longer half-life GHRH analogs, which extend the pulse window. The table below summarizes the field. None of these are sold legally without prescription in the US.

Molecular wireframe visualization of growth hormone releasing peptides on a dark screen
PeptideClassHalf lifeTypical role
SermorelinGHRH analog10 to 20 minRestore natural overnight pulse
TesamorelinGHRH analog, modified26 min in serumStronger pulse, FDA approved for HIV lipodystrophy
CJC 1295 with DACGHRH analog, long actingDays, not minutesSustained elevation, loses pulsatility
IpamorelinGHRP, selective2 hoursPulse amplification, minimal cortisol or prolactin
GHRP 2GHRP1 to 2 hoursPulse amplification, mild appetite increase
HexarelinGHRPApprox 1 hourStrong pulse but blunts response over time, rarely used long term

The cycle protocol

A standard 12 week sermorelin run looks like the schedule below. Adjust dose by clinician, not by self-titration. The five-on-two-off cadence reduces tachyphylaxis at the pituitary GHRH receptor over a long cycle.

WeekDoseCadenceLab checkNotes
1 to 4200 mcg5 on, 2 offBaseline IGF-1 doneSleep depth shifts first. Hold steady.
5 to 8200 to 300 mcg5 on, 2 offNone mid cycleSkin, hair, energy. Training recovery up.
9 to 12300 mcg5 on, 2 offFollow up IGF-1 at week 12Body composition window. Reassess.
Week 13Pause or maintainClinician callCompare IGF-1 to baselineDecide hold, lower, or cycle off 4 to 8 weeks.

Sourcing pathway in the United States

There are two channels for sermorelin in the US. One is legal, clinical, and traceable. The other is not, and is sold under a research-only label that buyers routinely ignore. The difference matters for purity, dose accuracy, and personal legal exposure.

Dark lab interface dashboard showing IGF-1 and protocol tracking data

Clinical pathway

Compounded prescription

  • Online consultation with a licensed clinician in your state
  • Baseline IGF-1 plus metabolic panel ordered
  • Prescription dispensed by a 503A or 503B compounding pharmacy
  • Sterile vial, accurate concentration, traceable batch
  • Sharps kit, dosing protocol, follow-up labs

View licensed provider

Research-only pathway

Grey market peptide vendor

  • Sold as research chemical, not for human consumption
  • No clinician oversight, no prescription, no liability
  • Purity and dose vary by batch and supplier
  • No medical record, no lab follow-up
  • Federal grey area for buyer, frank illegal for some sellers

Not recommended for any adult running protocols seriously.

Self-tracking log, what to measure

Sermorelin works on a slow curve. The signal arrives over weeks, not days, and shows up unevenly across markers. The tracking spec below catches the typical response without over-instrumenting.

Top down view of lab equipment, micropipettes and small vials on a matte black surface

  • Sleep depth, weeks 1 to 4

    Wearable deep sleep minutes, subjective restfulness on waking. Most consistent first signal.

  • Morning energy, weeks 1 to 4

    Subjective on a 1 to 10 scale at the same time each morning. Daily, no trend smoothing the first month.

  • Training recovery, weeks 4 to 8

    Time to feel ready for the next session after a hard lift or run. Notes on DOMS duration.

  • Body composition, weeks 8 to 12

    Same day of week, same time of day, same equipment. Waist circumference and weight at minimum. DEXA if possible at baseline and end.

  • IGF-1, week 12

    Follow up draw. Compare to baseline. This is the only objective biochemical signal the protocol moves predictably.

  • Fasting glucose, monthly

    Safety marker. GH downstream can shift insulin sensitivity. Flag any sustained rise.

Source it through a US licensed clinic in the United States, USA

Compounded sermorelin from a registered pharmacy, after a real consultation and lab with a US-licensed clinician. Refund if the clinician says no.

Start your consultation